Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brenda I. Hendriks-Stegeman"'
Autor:
C.E. van den Brink, S. C. van Buul-Offers, B. van der Burg, Brenda I. Hendriks-Stegeman, P. T. Van Der Saag, Maarten Jansen, Harry Vermeer
Publikováno v:
Clinical Endocrinology. 59:49-55
Summary objective Some patients develop side-effects even on relatively low doses of topically administered glucocorticoids (GCs), while others appear to be less sensitive to GCs. We have developed and validated a bioassay which can measure glucocort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bf5646f573816680207b390dfdd8d1d
https://doi.org/10.1046/j.1365-2265.2003.01793.x
https://doi.org/10.1046/j.1365-2265.2003.01793.x
Autor:
Harry Vermeer, Bart van der Burg, Brenda I. Hendriks-Stegeman, Maarten Jansen, Sylvia C. van Buul-Offers
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 88:277-284
To reduce the side effects of corticosteroid treatment, the administered dose of glucocorticoids (GCs) should be kept to a minimum while preserving therapeutically needed intracellular levels. Currently available assays to determine individual sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ac2ae7b0f4a6b37d44e67740dcfc09
https://doi.org/10.1210/jc.2002-020354
https://doi.org/10.1210/jc.2002-020354
Autor:
Brenda I. Hendriks-Stegeman, Pieternella Holthuizen, Peter C. van der Vliet, Maarten Jansen, Bert Bakker, Kevin D. Augustijn
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:1545-1550
The POU homeodomain containing transcriptional activator POU1F1, formerly called Pit1 or GHF-1, is required for the embryological determination and postnatal secretory function of the GH-, PRL-, and TSH-producing cells in the anterior pituitary. Seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14483cd01cac4b692e114e264a18b144
https://doi.org/10.1210/jcem.86.4.7371
https://doi.org/10.1210/jcem.86.4.7371
Autor:
Maarten Jansen, A. A. Verrijn Stuart, Brenda I. Hendriks-Stegeman, S. C. van Buul-Offers, Harry Vermeer
Publikováno v:
European journal of endocrinology. 150(1)
An altered cellular glucocorticoid (GC) sensitivity is associated with several pathophysiological conditions such as asthma, diabetes, or rheumatoid arthritis. Several bioassays have been developed and employed to assess cellular GC sensitivity of pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d1ec6bb50697a45285612d049ec35a
https://pubmed.ncbi.nlm.nih.gov/14713278
https://pubmed.ncbi.nlm.nih.gov/14713278
Autor:
Brenda I. Hendriks-Stegeman, Sylvia C. van Buul-Offers, Maarten Jansen, Denise van Suylekom, Harry Vermeer, Ger T. Rijkers
Publikováno v:
Molecular and cellular endocrinology. 218(1-2)
Individual variation in sensitivity to glucocorticoids (GCs) poses a dilemma to the clinician. Currently available assays to determine individual sensitivity to GCs either seem imprecise, or they are based on mitogen-activated lymphocytes, although m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9be461ec6fdb7dee6582acb9891c165
https://pubmed.ncbi.nlm.nih.gov/15130510
https://pubmed.ncbi.nlm.nih.gov/15130510
Publikováno v:
Endocrinology. 140(12)
Overexpression of human insulin-like growth factor II (IGF-II) in transgenic mice does not result in increased overall body growth. The IGF-II overexpression, however, specifically causes growth of the thymus and not of the spleen. We address the que
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c34857ed947b32d91da82b98e1f7954
https://pubmed.ncbi.nlm.nih.gov/10579353
https://pubmed.ncbi.nlm.nih.gov/10579353